Literature DB >> 19491284

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

B G Haffty1, D H Choi, S Goyal, A Silber, K Ranieri, E Matloff, M H Lee, M Nissenblatt, D Toppmeyer, M S Moran.   

Abstract

BACKGROUND: Despite significant differences in age of onset and incidence of breast cancer between Caucasian (CA), African-American (AA) and Korean (KO) women, little is known about differences in BRCA1/2 mutations in these populations. The purpose of this study is to evaluate the prevalence of BRCA1/2 mutations and the association between BRCA1/2 mutation status and secondary malignancies among young women with breast cancer in these three racially diverse groups.
METHODS: Patients presenting to our breast cancer follow-up clinics selected solely on having a known breast cancer diagnosis at a young age (YBC defined as age <45 years at diagnosis) were invited to participate in this study. A total of 333 eligible women, 166 CA, 66 AA and 101 KO underwent complete sequencing of BRCA1/2 genes. Family history (FH) was classified as negative, moderate or strong. BRCA1/2 status was classified as wild type (WT), variant of uncertain significance (VUS) or deleterious (DEL).
RESULTS: DEL across these three racially diverse populations of YBC were nearly identical: CA 17%, AA 14% and KO 14%. The type of DEL differed with AA having more frequent mutations in BRCA2, compared with CA and KO. VUS were predominantly in BRCA2 and AA had markedly higher frequency of VUS (38%) compared with CA (10%) and KO (12%). At 10-year follow-up from the time of initial diagnosis of breast cancer, the risk of secondary malignancies was similar among WT (14%) and VUS (16%), but markedly higher among DEL (39%).
CONCLUSIONS: In these YBC, the frequency of DEL in BRCA1/2 is remarkably similar among the racially diverse groups at 14%-17%. VUS is more common in AA, but aligns closely with WT in risk of second cancers, age of onset and FH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491284     DOI: 10.1093/annonc/mdp051

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  25 in total

1.  Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.

Authors:  Anne Marie McCarthy; Mirar Bristol; Susan M Domchek; Peter W Groeneveld; Younji Kim; U Nkiru Motanya; Judy A Shea; Katrina Armstrong
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

2.  BRCA sequencing and large rearrangement testing in young Black women with breast cancer.

Authors:  Tuya Pal; Devon Bonner; Deborah Cragun; Sharland Johnson; Mohammad Akbari; Lily Servais; Steven Narod; Susan Vadaparampil
Journal:  J Community Genet       Date:  2013-08-29

3.  Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.

Authors:  Haeyoung Kim; Dae-Yeon Cho; Doo Ho Choi; Gee Hue Jung; Inkyung Shin; Won Park; Seung Jae Huh; Sung-Won Kim; Sue K Park; Jong Won Lee; Seok Jin Nam; Jeong Eon Lee; Won Ho Gil; Seok Won Kim
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

4.  Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.

Authors:  E Comen; M Davids; T Kirchhoff; C Hudis; K Offit; M Robson
Journal:  Breast Cancer Res Treat       Date:  2011-03-11       Impact factor: 4.872

5.  Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer.

Authors:  Orland Diez; Amadeu Pelegrí; Neus Gadea; Sara Gutiérrez-Enríquez; Miriam Masas; Anna Tenés; Nina Bosch; Judith Balmaña; Begoña Graña
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

6.  Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Authors:  Julia Fehniger; Feng Lin; Mary S Beattie; Galen Joseph; Celia Kaplan
Journal:  J Genet Couns       Date:  2013-05-12       Impact factor: 2.537

Review 7.  Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?

Authors:  Thomas C Randall; Katrina Armstrong
Journal:  Curr Treat Options Oncol       Date:  2016-08

8.  Occurrence of breast cancer subtypes in adolescent and young adult women.

Authors:  Theresa H M Keegan; Mindy C DeRouen; David J Press; Allison W Kurian; Christina A Clarke
Journal:  Breast Cancer Res       Date:  2012-03-27       Impact factor: 6.466

9.  Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.

Authors:  Dirce Maria Carraro; Maria Aparecida Azevedo Koike Folgueira; Bianca Cristina Garcia Lisboa; Eloisa Helena Ribeiro Olivieri; Ana Cristina Vitorino Krepischi; Alex Fiorini de Carvalho; Louise Danielle de Carvalho Mota; Renato David Puga; Maria do Socorro Maciel; Rodrigo Augusto Depieri Michelli; Eduardo Carneiro de Lyra; Stana Helena Giorgi Grosso; Fernando Augusto Soares; Maria Isabel Alves de Souza Waddington Achatz; Helena Brentani; Carlos Alberto Moreira-Filho; Maria Mitzi Brentani
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

10.  Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.

Authors:  Jae Myoung Noh; Doo Ho Choi; Hyejin Baek; Seok Jin Nam; Jeong Eon Lee; Jong Won Kim; Chang-Seok Ki; Won Park; Seung Jae Huh
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.